Known AID targets (e.g., IRF4, XBP1) were found to be mutated in some cases of our study cohort of progressed precursors as well, confirming the assumption that aberrant AID activity contributes to shaping the genomic landscape and the initiation of MM [31,78,80]. The gene discussed is IRF4; the disease is Miyoshi myopathy.